COVID-19 in Neonates and Infants: Progression and Recovery
Khuen Foong Ng, Srini Bandi, Paul Bird, Julian W. Tang
Abstract
Between March 10, 2020 and April 17, 2020, of 8/70 (11.4%) SARS-CoV-2 positive infants that presented, 5/8 (63%) developed fever, 4/8 (50%) had lower respiratory tract involvement, 2/8 (25%) had neutropenia and thrombocytosis, and 4/8 infants (50%) were treated for suspected sepsis with broad-spectrum antibiotics. Only 1/8 (13%) required pediatric intensive care. All patients were eventually discharged home well.
Topics & Concepts
MedicineNeutropeniaThrombocytosisSepsisPediatricsCoronavirus disease 2019 (COVID-19)Intensive careAntibioticsLower respiratory tract infectionPneumonia2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Broad spectrumRespiratory tract infectionsIntensive care medicineInternal medicineRespiratory systemVirologyChemotherapyInfectious disease (medical specialty)OutbreakDiseaseCombinatorial chemistryBiologyPlateletMicrobiologyChemistryCOVID-19 Impact on ReproductionCOVID-19 Clinical Research StudiesNeonatal Respiratory Health Research